AXIOGEN · RESEARCH · ATLAS · 2026

The aesthetics consumer, finally on the record.

Pharma has spent two decades buying surveys of office managers and panels of three hundred patients to understand a market of fifty million. The Axiogen Aesthetics Sentiment Atlas ends that era. One hundred twenty-four thousand seven hundred and five real patient utterances. Six hundred and forty micro regions. Forty-five states. Three and a half years. One ontology. Three volumes.

Open the Atlas See what it replaces

124,705

Real consumer utterances

640

Micro regions

States covered

3.5 yr

Longitudinal span

ρ = 0.780

Attainment ratio

94.9%

Conformal coverage at 95%

THE THESIS

The Atlas is not a market report. It is a census-grade record of the U.S. aesthetics consumer, a validated forward-simulator of post-launch sentiment, and a published calibration standard that makes both defensible inside a Fortune-500 biostats group.

CHAPTER 01 — FINDINGS

Four numbers that redraw the category.

01 / 04 → 04 / 04
HEADLINE NUMBERS

+0.299

Mean selection-bias correction

Across 25 sentiment domains. Real reviews are systematically inflated; the calibration step quantifies by how much.

r = 0.785

Synthetic-vs-real correlation

Persona-conditioned synthetic reviews track real consumer sentiment at near-ceiling rank-order correlation — without a panel.

99.8%

Domain coverage

Of all 124,705 reviews, only 0.2% fall outside the 25-domain ontology. The framework is comprehensive for medical aesthetics.

84,376

Owner-response observations (PSM)

The largest causal analysis ever published of how owner replies move sentiment, controlled for selection bias.

CHAPTER 02 — WHAT IT REPLACES

The category it makes obsolete.

These are the line items pharma teams currently buy to understand consumer voice in medical aesthetics. The Atlas exceeds each on its own dimension — and is the first to publish a calibration paper at all.

Vendor / category	What they sell	Sample N	Lag	Cost
QSight / M3 Aesthetics	Syndicated aesthetics consumer reports	300 – 1,500	3 – 6 mo	$40K – $150K
Spherix Global Insights	Quarterly aesthetics & derma trackers	100 – 300 / wave	1 quarter	$30K – $80K / yr
Sermo · ZoomRx · M3 Global	HCP & patient panel surveys	200 – 500	4 – 12 weeks	$20K – $100K
Brandwatch · Sprinklr · Sprout	Generic social listening	Volume, unstructured	Real-time	$50K – $300K / yr
IQVIA · Symphony · Komodo	Rx & claims real-world data overlays	Massive (Rx)	1 – 2 mo	$100K – $1M+
GlobalData · Triangle Insights	Industry market reports	Desk + ~200 primary	6 mo	$30K – $80K
AmSpa industry surveys	Annual aesthetics industry pulse	500 – 1,000	1 yr	Membership-tier
Axiogen Aesthetics Sentiment Atlas	Census-grade consumer record + validated forward-simulator	124,705	Continuous	Atlas access

Approximate ranges, drawn from public statements of work and vendor data sheets. The Atlas is the only entry on this list with longitudinal coverage measured in years and a published per-domain calibration paper.

CHAPTER 03 — THREE VOLUMES

One Atlas. Three instruments.

Every volume draws from the same governed substrate our customers run on. No one-off scrapes, no survey panels, no lookalike modeling. The research pipeline is a read-replica of the live Axiogen ontology — versioned, provenance-graded, reproducible.

I · II · III
RECORD · FORECAST · STANDARD

Volume I · The Record

The National Atlas

Available

The largest empirical record of U.S. medical aesthetics consumer sentiment ever assembled.

One hundred twenty-four thousand seven hundred and five real patient utterances, scored across twenty-five validated sentiment domains. Six hundred and forty micro regions, forty-five states, three and a half years of longitudinal coverage. The first time the U.S. aesthetics consumer has been observed at census scale, in their own words, without a panel.

Open Volume I124,705 utterances · 640 micro regions · 45 states

What's inside

Consumer-voice scoring across 25 SSR domains
Geographic & business-category benchmarking
Owner-response causal analysis (PSM, n = 84,376)
Latent-topic discovery (BERTopic) and spatial clustering
Perceptual-map (MDS) of 640 micro regions in strategic groups

Audience

Commercial leadership · Brand · Field & Territory ops

Decision it underwrites

Launch sequencing, indication prioritization, geographic deployment, account-level prospect ranking.

Volume II · The Forecast

The Synthetic Population

Available

A validated forward-simulator of consumer sentiment — calibrated to a 124K-review ground truth.

Fifteen thousand five hundred persona-conditioned synthetic reviews, validated against the National Atlas at r = 0.785 rank-order correlation. The first published methodology that lets pharma interrogate sentiment for cohorts that do not write public reviews — first-time injectors, needle-averse patients, regulatory-sensitive populations. Pre-launch, by cohort, by concept, by persona.

Open Volume II15,500 synthetic reviews · r = 0.785 vs. real

What's inside

Persona-conditioned synthetic reviews — 20 treatment concepts
Selection-bias correction across 25 domains (mean δ = +0.299)
Synthetic-vs-real distribution overlap by domain
"Silent concerns" surfacing — what patients feel but never post
Discrimination signals: price-sensitivity, experience, fear cohorts

Audience

Insights & Market Research · Med Affairs · Brand strategy

Decision it underwrites

Pre-launch positioning, message testing, payer/MLR risk surfacing, cohort prioritization, indication expansion modeling.

Volume III · The Standard

The Calibration Standard

Gated · Request Access

The methodological floor that makes Volumes I and II defensible inside a Fortune-500 biostats group.

Three-stage validation: anchor reliability, Bayesian bias correction, and conformal prediction. Attainment ratio ρ = 0.780 against a 0.999 human-human ceiling. Conformal coverage 94.9% at a 95% target. Mean interval width 2.50. The document any competitor would need to read to attempt to copy the work — which is why it is gated.

Request accessρ = 0.780 · 94.9% conformal coverage · CI width 2.50

What's inside

Anchor validation: split-half R^xx / R^xy across 25 domains
Bayesian calibration: prior → posterior shifts, uncertainty reduction
Conformal prediction: per-domain CIs, empirical coverage at 95%
Integrated three-stage verdict by domain
Methodology appendices, reproducible against the deployed substrate

Audience

Biostatistics · RWD · Analytics · Procurement & MLR

Decision it underwrites

Procurement defensibility, internal validation memos, biostats sign-off, methodology benchmarking.

CHAPTER 04 — THE FLOOR

No one else publishes a calibration paper. That is not an accident.

QSight, Spherix, Sermo, ZoomRx, Brandwatch — none of them publish per-domain coverage tables. None of them publish Bayesian priors. None of them publish anchor-validation split-half coefficients. They cannot, because their methods will not survive that level of disclosure. Volume III of the Atlas is the document that does — and it is the one volume your biostats team will ask for first.

ρ = 0.780

Anchor attainment

AI-to-human correlation against a 0.999 human-human ceiling.

+0.299

Bayesian correction

Mean per-domain bias correction across 25 sentiment domains.

94.9%

Conformal coverage

Empirical coverage at a 95% target — well-calibrated uncertainty.

2.50

Mean CI width

Across all 25 domains. Narrower intervals on Immediate Results, Patient Referral, Social Media.

CHAPTER 05 — ON DECK

Beyond Title The Digital Opinion Leader & Provider Sentiment Thesis

Volume IV · On Deck

A unified thesis combining Digital Opinion Leadership (social-media velocity, peer reactions, longitudinal sentiment) with overall provider sentiment from the consumer record — outpacing conventional KOL tier as a leading indicator of practice influence.

OutlinedETA · 2027

CHAPTER 06 — INQUIRIES

If your team buys panels and trackers, we should talk.

The Atlas is a public artifact. The substrate underneath it is the deployed Axiogen ontology — the same one our commercial, medical, and corporate customers query every day. If you want to interrogate the data behind a finding, or carve a custom slice for your launch, the door is open.

Request Volume III Read the Manifesto

ATLAS · 2026 EDITION · BUILT IN CALIFORNIA